Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-05-16
1997-05-27
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514450, 514400, 514471, A61K 3143, A61K 31335, A61K 31415, A61K 3134
Patent
active
056332440
ABSTRACT:
A synergistic pharmaceutical combination or composition is disclosed for the treatment of gastritis and peptic ulcer containing a therapeutic amount of a histamine H.sub.2 receptor blocking agent, which increases intragastric pH, and an acid degradable antibacterial compound. In particular, the combination is directed to the treatment of infections by Helicobacter pylori by raising the bioavailability of acid degradable antibacterial compounds.
REFERENCES:
patent: 5013743 (1991-05-01), Iwahi et al.
patent: 5407688 (1995-04-01), Place
McDermott, et al., Science, The Absorption of Orally Administered Penicillin, Mar. 22, 1946, pp. 359-361.
McNulty, et al., Eur. J. Clin. Microbiol. Infect. Dis., Susceptibility of Clinical Isolates, Aug., 1988, pp. 566-569.
The Lancet, Clarithromycin and Omeprazole, vol. 340, Jul. 25, 1992, p. 239.
Goodwin, Worsley, Peptic Ulcer Disease, 1992, Current Science, 8:122-127.
Loo, Sherman, Matlow; Helicobacter pylori Infection, Anti-microbial Agents & Chemotherapy, May, 1992, pp. 1133-1135.
P. Unge, et al. "Does Omeprazole, 40 mg o.m. improve antimicrobial therapy directed towards gastric Campylobacter-pylori in patients . . . " Scandinavian Journal of Gastroeneterology 1989, 24 (Suppl. 166) p. 184 (Abstract).
P. Unge, et al. "Does Omeprazole improve antimicrobial therapy directed towards gastric Campylobacter-pylori in patients with antral gastritis" Scandinavian Journal of Gastroenterology 1989, 24 (Suppl. 167) pp. 49-54 (Article).
"Which regimen for H pylori eradication?" SCRIP No. 1861, p. 23; Oct. 5, 1993.
S. Rune, "Helicobacter pylori, Peptic Ulcer Disease and Inhibition of Gastric Acid Secretion" Digestion 1992; 51 (Suppl. 1):11-16.
Czinn et al, Chemical Abstracts, vol. 105, No. 17, Abstract #149590m, 1986.
Yoshinobu et al, Chemical Abstracts, vol. 109, No. 19, Abstract #163262v, 1988.
Graham et al, Biosis Abstract, BR41:125113, 1991.
Tzelepi et al, Biological Abstracts, vol. 93, No. 2, Abstract #14092, 1992.
Eek Arne T.
Sjostrand Sven E.
Astra Aktiebolag
Cintins Marianne M.
Jarvis William R. A.
LandOfFree
Synergistic combination of a substance with gastric acid secreti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synergistic combination of a substance with gastric acid secreti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic combination of a substance with gastric acid secreti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2329184